Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients

Leuk Res. 2011 Aug;35(8):1008-13. doi: 10.1016/j.leukres.2011.03.001. Epub 2011 Mar 26.

Abstract

Nestin is considered to be a characteristic marker of multipotent proliferative precursors found in some embryonic and fetal tissues. Its expression might be a suitable diagnostic and prognostic indicator of malignancy and a potential marker of cancer stem cells in solid tumors. Unexpectedly, nestin protein was detected in mature CD138(+)CD38(+) plasma cells of multiple myeloma patients and statistical analysis confirmed significant differences between myeloma patients and control group without hematological malignancy. Our results represent the first evidence of nestin expression in multiple myeloma. Further studies are required to elucidate the role of this protein in multiple myeloma.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism*
  • Blotting, Western
  • Case-Control Studies
  • Female
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Intermediate Filament Proteins / metabolism*
  • Male
  • Middle Aged
  • Multiple Myeloma / metabolism*
  • Neoplastic Stem Cells / metabolism*
  • Nerve Tissue Proteins / metabolism*
  • Nestin
  • Pilot Projects
  • Plasma Cells / metabolism*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • Intermediate Filament Proteins
  • NES protein, human
  • Nerve Tissue Proteins
  • Nestin